Below are the most recent publications written about "Drug Compounding" by people in Profiles.
-
Porat-Dahlerbruch G, Struppe J, Quinn CM, Gronenborn AM, Polenova T. 19F fast MAS (60-111?kHz) dipolar and scalar based correlation spectroscopy of organic molecules and pharmaceutical formulations. Solid State Nucl Magn Reson. 2022 12; 122:101831.
-
Rochani A, Nguyen V, Becker R, Kaushal G. Stability-indicating HPLC method to determine the stability of extemporaneously prepared vancomycin oral solution cups. Am J Health Syst Pharm. 2022 Jan 01; 79(1):e34-e40.
-
Knudson CJ, Alves-Peixoto P, Muramatsu H, Stotesbury C, Tang L, Lin PJC, Tam YK, Weissman D, Pardi N, Sigal LJ. Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T?cells against a lethal viral infection. Mol Ther. 2021 09 01; 29(9):2769-2781.
-
Kleinmann N, Matin SF, Pierorazio PM, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky S, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Stern J, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Adibi M, Amin MB, Seltzer E, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Schoenberg M, Lerner SP. Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. Lancet Oncol. 2020 06; 21(6):776-785.
-
Yellepeddi VK, Joseph A, Nance E. Pharmacokinetics of nanotechnology-based formulations in pediatric populations. Adv Drug Deliv Rev. 2019 Nov - Dec; 151-152:44-55.
-
Bushra R, Rehman A, Ghayas S, Zafar F, Ali H, Shafiq Y, Khalid F, Khan MA, Hanif A, Mustapha O. Formulation design, characterization and optimization of cinitapride (1mg) immediate release tablets using direct compression technology. Pak J Pharm Sci. 2018 Nov; 31(6 (Supplementary):2725-2731.
-
Rodon J, P?rez-Fidalgo A, Krop IE, Burris H, Guerrero-Zotano A, Britten CD, Becerra C, Schellens J, Richards DA, Schuler M, Abu-Khalaf M, Johnson FM, Ranson M, Edenfield J, Silva AP, Hackl W, Quadt C, Demanse D, Duval V, Baselga J. Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer. Cancer Chemother Pharmacol. 2018 08; 82(2):285-298.
-
Rehman A, Bushra R, Beg AE, Ali H, Zafar F, Ashfaq M, Alam S, Mustapha O, Shafique S. Effects of superdisintegrants in oral dissolving formulation of cinitapride tablets. Pak J Pharm Sci. 2018 Mar; 31(2(Suppl.)):643-650.
-
Penazzato M, Gnanashanmugam D, Rojo P, Lallemant M, Lewis LL, Rocchi F, Saint Raymond A, Ford N, Hazra R, Giaquinto C, Belew Y, Gibb DM, Abrams EJ. Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations. Clin Infect Dis. 2017 Jun 01; 64(11):1597-1603.
-
Greco CT, Andrechak JC, Epps TH, Sullivan MO. Anionic Polymer and Quantum Dot Excipients to Facilitate siRNA Release and Self-Reporting of Disassembly in Stimuli-Responsive Nanocarrier Formulations. Biomacromolecules. 2017 Jun 12; 18(6):1814-1824.